Picture of Celltrion Healthcare Co logo

091990 — Celltrion Healthcare Co News Story

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousLarge Cap

Brief: Celltrion USA says Ventegra Will Place FDA-Approved Biosimilar To Avastin , Vegzelma On Its Commercial Formulary As A Preferred Brand

Dec 11 (Reuters) - Celltrion Healthcare Co Ltd
 091990.KQ :
    * CELLTRION USA - VENTEGRA WILL PLACE FDA-APPROVED
BIOSIMILAR TO
AVASTIN, VEGZELMA ON ITS COMMERCIAL FORMULARY AS A PREFERRED
BRAND

Source text for Eikon:  ID:nPn93xHw5a 
Further company coverage:  091990.KQ 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Celltrion Healthcare Co

See all news